# Diffusion Pharmaceuticals
 (stock symbol: DFFN) Logo in transparent PNG format

## Diffusion Pharmaceuticals
 Logo large

### Diffusion Pharmaceuticals
 Logo large Download PNG (28.54 KB)

![Diffusion Pharmaceuticals
 Logo large Download PNG (28.54 KB)](/img/orig/DFFN_BIG-3e13a007.png)

## Diffusion Pharmaceuticals
 Logo icon format

### Diffusion Pharmaceuticals
 Logo icon format Download PNG (34.74 KB)

![Diffusion Pharmaceuticals
 Logo icon format Download PNG (34.74 KB)](/img/orig/DFFN-85af6ed6.png)

## About Diffusion Pharmaceuticals


Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

1. Website domain: diffusionpharma.com
2. Employees: 16
3. Marketcap: $7.83 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
